X0202 3/A 2007-10-16 2007-10-26 0 0000897075 REPROS THERAPEUTICS INC. RPRX 0001350855 Efficacy Capital, Ltd. 11622 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 0 0 1 0 0001366074 Lappe Mark 11622 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 0 0 1 0 0001366268 Kayyem Jon Faiz 11622 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 0 0 1 0 0001366073 Efficacy Biotech Fund L.P. 11622 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 0 0 1 0 0001366071 Efficacy Biotech Fund LTD 11622 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 0 0 1 0 0001366070 Efficacy Biotech Master Fund Ltd. 11622 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 0 0 1 0 Common Stock 1463413 I By investment funds Includes 1,299,413 shares held by Efficacy Biotech Master Fund Ltd., a Bermuda Exempted Mutual Fund Company, 104,000 shares held by FMG Special Situations Fund and 60,000 shares held by Ronin Capital, LLC. The Reporting Company acts as an investment advisor with investment and voting discretion over portfolio investments. The Reporting Company is an indirect beneficial owner of the reported securities.. Exhibit List Exhibit 99 -Joint Filer Information (Previously filed on Form 3 with the Securities and Exchange Commission on October 26, 2007, and incorporated herein by reference.) /s/ Efficacy Capital Ltd. By: Mark Lappe Managing Partner 2007-11-02